aclidinium bromide and its Impurities
Aclidinium Bromide is a much higher propensity to bind to muscarinic receptors than nicotinic receptors. FDA approved on July 24, 2012. Aclidinium is an anticholinergic for the long-term management of chronic obstructive pulmonary disease. Reference standards of Aclidinium Bromide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
(3R,3'R)-1,1'-(propane-1,3-diyl)bis(3-(2-hydroxy-2,2-di(thiophen-2-yl)acetoxy)quinuclidin-1-ium) Bromide
(3R,3'R)-1,1'-(propane-1,3-diyl)bis(3-(2-hydroxy-2,2-di(thiophen-2-yl)acetoxy)quinuclidin-1-ium) Bromide
Catalogue No.:PA 28 0811004
CAS :
NA
Molecular Formula : C37H44Br2N2O6S4
Molecular Weight : 900.82
